# The Role of Glucocorticoids to Maintain Energy Homeostasis During Starvation (Gluco-Starve)

> **NCT05919992** · EARLY_PHASE1 · COMPLETED · sponsor: **Eleonora Seelig** · enrollment: 24 (actual)

## Conditions studied

- Glucocorticoid Effect

## Interventions

- **DRUG:** Metyrapone 250 mg Oral Tablets
- **DRUG:** Hydrocortisone 19.9mg s.c., pulsatile with a flow rate of 10μl/s
- **DRUG:** Placebo 250 mg Tablets
- **DRUG:** Placebo (0,9% NaCl solution)

## Key facts

- **NCT ID:** NCT05919992
- **Lead sponsor:** Eleonora Seelig
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-15
- **Primary completion:** 2024-07-25
- **Final completion:** 2024-07-25
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05919992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05919992, "The Role of Glucocorticoids to Maintain Energy Homeostasis During Starvation (Gluco-Starve)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05919992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*